Strengthening IP rights will benefit India, US judge tells international seminar

20 February 2006

Strengthening intellectual property rights will help India make optimum use of its manufacturing capability and its resources, according to Judge Randall Rader of the US Court of Appeals of the Federal Circuit, which oversees all patent cases in the USA. Speaking at an international seminar on IP litigation in Hyderabad, India, Judge Rader said that India's strong pool of scientists, engineers, doctors and its creativity will benefit. Pharmabiz.com quoted the Judge as noting that, while it could take 10 years or more for India to rival the manufacturing standards of Japan and the west, the country could quickly be on the same level in terms of IP protection.

First, he said, India needs to understand the value and benefit of enforcing IP rights through the creation of patent laws that are the equal of international standards, suggesting the creation of specialized courts for improving enforcement of IP. India also needs to train lawyers who are skilled in enforcing IP protection not only domestically, but also abroad, he added.

Other speakers agree

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight